IRIS
PREVITI, Santo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.160
NA - Nord America 862
AS - Asia 148
AF - Africa 8
SA - Sud America 4
OC - Oceania 1
Totale 2.183
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 862
IT - Italia 315
IE - Irlanda 301
SE - Svezia 176
PL - Polonia 167
CN - Cina 109
AT - Austria 56
FR - Francia 42
DE - Germania 32
BE - Belgio 28
SG - Singapore 23
FI - Finlandia 19
GB - Regno Unito 9
IN - India 9
CO - Colombia 4
CZ - Repubblica Ceca 4
VN - Vietnam 4
DZ - Algeria 3
NL - Olanda 3
CH - Svizzera 2
KR - Corea 2
NG - Nigeria 2
EG - Egitto 1
ES - Italia 1
GR - Grecia 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
TZ - Tanzania 1
UA - Ucraina 1
Totale 2.183
Salva come PNG Salva come JPEG
Città #
Dublin 301
Chandler 255
Warsaw 166
Nyköping 152
Messina 115
Ashburn 63
Vienna 56
Beijing 54
Princeton 50
Ann Arbor 38
Medford 34
Des Moines 30
Jacksonville 18
Singapore 17
Brussels 16
Dearborn 16
Cambridge 14
Modica 14
Montpellier 12
San Mateo 12
Jinan 9
Bari 8
Catania 8
Ixelles-Elsene 8
Houston 7
Rome 7
Siderno 7
Wilmington 7
Berlin 6
Francavilla di Sicilia 6
Haikou 6
Helsinki 6
Shenyang 6
Taizhou 6
Aversa 5
Boardman 5
Francofonte 5
Riposto 5
Southampton 5
Borghetto Santo Spirito 4
Brno 4
Cagliari 4
Dong Ket 4
Medellín 4
Munich 4
New Delhi 4
Zhengzhou 4
Caltagirone 3
Falls Church 3
Fontaniva 3
Fuzhou 3
Hangzhou 3
Hebei 3
Hyderabad 3
Lanzhou 3
Lentini 3
Milan 3
Patti 3
Rosarno 3
Seattle 3
Avola 2
Brussel 2
Dongguan 2
Ferrara 2
Hanover 2
Katsina 2
Mazzarino 2
Milazzo 2
Nanjing 2
Orsay 2
Piazza Armerina 2
Redmond 2
Redwood City 2
Riva 2
Saint-denis 2
Siracusa 2
Tianjin 2
Turin 2
Zurich 2
Aci Sant'Antonio 1
Aci Sant'antonio 1
Augusta 1
Bordeaux 1
Cardiff 1
Chengdu 1
Chisinau 1
Christchurch 1
Cupertino 1
Den Haag 1
Floridia 1
Gravina di Catania 1
Guangzhou 1
Jiaxing 1
Kielce 1
Lappeenranta 1
Las Vegas 1
Leonforte 1
Los Angeles 1
Mainz 1
Makumbako 1
Totale 1.685
Salva come PNG Salva come JPEG
Nome #
Design, synthesis and biological evaluation of novel inhibitors of rhodesain, cysteine protease of Trypanosoma brucei rhodesiense, as antitrypanosomal agents 253
Synthesis and biological evaluation of novel peptidomimetics as rhodesain inhibitors 86
Design, synthesis and biological evaluation of novel rhodesain inhibitors for the treatment of Human African Trypanosomiasis 81
Design, synthesis and biological evaluation of novel dipeptide-like rhodesain inhibitors containing a conformationally constrained 3-bromoisoxazoline warhead 79
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 75
Development of Novel Peptide-based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs) 73
Development of novel irreversible rhodesain inhibitors as antitrypanosomal agents. 71
Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases 67
Development of novel 1,4-benzodiazepine-based Michael acceptors as antitrypanosomal agents 67
The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis 62
Drug combination studies of curcumin and genistein against rhodesain of Trypanosoma brucei rhodesiense 59
Development of novel peptide-based Michael acceptors targeting rhodesain and falcipain-2 for the treatment of neglected tropical diseases (NTDs) 58
Development of novel benzodiazepine-based peptidomimetics as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 55
Evaluation of curcumin irreversibility 54
Development of novel dipeptide-like rhodesain inhibitors containing the 3-bromoisoxazoline warhead in a constrained conformation 54
Design and NMR conformational analysis in solution of β5i-selective inhibitors of immunoproteasome 52
Design, synthesis and biological evaluation of potent rhodesain inhibitors as antitrypanosomal agents 52
Development of novel amides as non covalent inhibitors of immunoproteasome 51
Discovery of novel peptidomimetics containing a benzodiazepine scaffold as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 51
Development of novel 1,4-benzodiazepines as antitrypanosomal agents 50
null 50
Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain 46
Development of novel Michael acceptors targeting rhodesain as antitrypanosomal agents 46
Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 45
Neurotensin, a multi-faceted peptide 43
Development of peptidyl Michael acceptors for S3 pocket investigation of rhodesain, cysteine protease of Trypanosoma brucei rhodesiense 43
Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei hodesiense 41
Development of novel peptide-based Michael acceptors targeting rhodesain for the treatment of human african trypanosomiasis 40
Optimization Strategy of Novel Peptide-Based Michael Acceptors for the Treatment of Human African Trypanosomiasis 40
Development of isoquinolinone derivatives as immunoproteasome inhibitors. 31
Optimization of radiopharmaceuticals based on neurotensin[8-13] for NTS1-positive tumours imaging 30
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors 29
Drug synergism: studies of combination of RK-52 and curcumin against rhodesain of Trypanosoma brucei rhodesiense 29
Insightful backbone modifications preventing proteolytic degradation of neurotensin analogs improve NTS1-induced protective hypothermia 29
Lead discovery of SARS-CoV-2 main protease inhibitors through covalent docking-based virtual screening 29
null 27
Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B 25
Dual inhibition of parasitic targets: a valuable strategy to treat malaria and neglected tropical diseases 23
Falcipain-2 and Falcipain-3 Inhibitors as Promising Antimalarial Agents 23
Development of novel peptidyl nitriles targeting rhodesain and falcipain-2 for the treatment of sleeping sickness and malaria 23
null 21
null 21
Silicon-containing neurotensin analogues as radiopharmaceuticals for NTS1-positive tumors imaging 21
Drug combination studies of the dipeptide nitrile CD24 with curcumin: a new strategy to synergistically inhibit rhodesain of trypanosoma brucei rhodesiense 20
Optimized opioid-neurotensin multitarget peptides: from design to structure−activity relationship studies 20
Drug combination studies of PS-1 and quercetin against rhodesain of Trypanosoma brucei rhodesiense 19
Structure-based design of melanocortin 4 receptor ligands based on the SHU-9119-hMC4R cocrystal structure 18
Peptidyl Vinyl Ketone Irreversible Inhibitors of Rhodesain: Modifications of the P2 Fragment 17
Development of reduced peptide bond pseudopeptide Michael acceptors for the treatment of Human African Trypanosomiasis 16
Design, synthesis, and biological evaluation of the first radio-metalated neurotensin analogue targeting neurotensin receptor 2 15
Monoclonal antibodies: the greatest resource to treat multiple myeloma 13
Development of Novel Benzodiazepine-Based Peptidomimetics as Inhibitors of Rhodesain from Trypanosoma brucei rhodesiense 13
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors 11
null 11
Dipeptide nitrile CD34 with curcumin: a new improved combination strategy to synergistically inhibit rhodesain of Trypanosoma brucei rhodesiense 11
Identification of dual inhibitors targeting main protease (Mpro) and cathepsin L as potential anti-SARS-CoV‑2 agents 9
Metabolically stable neurotensin analogs exert potent and long-acting analgesia without hypothermia 9
The inhibition of NS2B/NS3 protease: a new therapeutic opportunity to treat Dengue and Zika virus infection 7
Opening the amino acid toolbox for peptide-based NTS2-selective ligands as promising lead compounds for pain management 7
Influence of amino acid size at the P3 position of N-Cbz-tripeptide Michael acceptors targeting falcipain-2 and rhodesain for the treatment of malaria and human african trypanosomiasis 6
Totale 2.427
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.559
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.559
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020233 16 7 11 5 9 31 29 18 8 59 28 12
2020/2021268 15 15 50 9 37 30 14 11 49 23 8 7
2021/2022295 6 30 3 23 9 7 44 8 3 20 20 122
2022/2023997 63 97 43 78 55 105 47 79 369 4 50 7
2023/2024326 43 47 18 61 45 11 7 6 4 29 37 18
2024/202518 18 0 0 0 0 0 0 0 0 0 0 0
Totale 2.427